ArticleSleep & breathing = Schlaf & Atmung2026
Characterizing early response and adherence to hypoglossal nerve stimulation: real-world evidence from a single-center cohort.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeReal-world predictors of early response to hypoglossal nerve stimulation (HGNS) remain inadequately characterized. We aimed to examine baseline characteristics, oximetry patterns, and adjunctive therapies associated with treatment response in a routine clinical HGNS cohort.
methodsWe conducted a retrospective cohort study of adults receiving HGNS at a tertiary sleep center (2019–2025). Treatment response was defined as apnea-hypopnea index by 4% criteria (AHI4%) < 15 events/hour on first post-implant polysomnography. Baseline demographics, polysomnography characteristics including oximetry banding patterns, adjunctive medication exposure, and device adherence were compared between responders and non-responders using Wilcoxon rank-sum and Fisher exact tests.
resultsAmong 56 implanted patients, 35 had post-implant polysomnography with complete AHI4% data. Twenty-eight (80%) were responders; median AHI4% decreased from 27.1 to 7.0 events/hour. Responders had lower body mass index (28.6 vs. 31.1 kg/m², p = 0.035) and baseline AHI4% (20.3 vs. 37.5 events/hour, p = 0.021). All non-responders demonstrated oximetry banding patterns compared to 77% of responders (p = 0.16). Response rates using AHI3% criteria were markedly lower (31% [11/36]).
conclusionsLower BMI was associated with early HGNS response. Oximetry banding and adjunctive pharmacotherapy were common among non-responders, suggesting opportunities for combination therapeutic approaches. The substantial gap between AHI4% and AHI3% response rates highlights persistent arousal-based disturbances that may warrant additional intervention.
Indexed as
Identifiers
42020616What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.